ORPEA (ORP.PA)

FR001400NLM4 - Common Stock

12.158  -0.09 (-0.75%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ORP. ORP was compared to 23 industry peers in the Health Care Providers & Services industry. ORP has a bad profitability rating. Also its financial health evaluation is rather negative. ORP is valied quite expensively at the moment, while it does show a decent growth rate.



2

1. Profitability

1.1 Basic Checks

ORP had negative earnings in the past year.
In the past year ORP had a positive cash flow from operations.
Of the past 5 years ORP 4 years were profitable.
Each year in the past 5 years ORP had a positive operating cash flow.

1.2 Ratios

ORP has a Return On Assets of -27.42%. This is amonst the worse of the industry: ORP underperforms 95.65% of its industry peers.
Industry RankSector Rank
ROA -27.42%
ROE N/A
ROIC N/A
ROA(3y)-8.82%
ROA(5y)-4.57%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

ORP does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

0

2. Health

2.1 Basic Checks

ORP does not have a ROIC to compare to the WACC, probably because it is not profitable.
ORP has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for ORP remains at a similar level compared to 5 years ago.
ORP has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of -0.67, we must say that ORP is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of ORP (-0.67) is worse than 86.96% of its industry peers.
The Debt to FCF ratio of ORP is 27.09, which is on the high side as it means it would take ORP, 27.09 years of fcf income to pay off all of its debts.
ORP has a worse Debt to FCF ratio (27.09) than 73.91% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 27.09
Altman-Z -0.67
ROIC/WACCN/A
WACC4.71%

2.3 Liquidity

ORP has a Current Ratio of 0.17. This is a bad value and indicates that ORP is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of ORP (0.17) is worse than 95.65% of its industry peers.
A Quick Ratio of 0.16 indicates that ORP may have some problems paying its short term obligations.
ORP has a worse Quick ratio (0.16) than 95.65% of its industry peers.
Industry RankSector Rank
Current Ratio 0.17
Quick Ratio 0.16

4

3. Growth

3.1 Past

ORP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -6733.33%.
ORP shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.89%.
ORP shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.33% yearly.
EPS 1Y (TTM)-6733.33%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-37.04%
Revenue 1Y (TTM)8.89%
Revenue growth 3Y7.76%
Revenue growth 5Y8.33%
Revenue growth Q2Q10.67%

3.2 Future

Based on estimates for the next years, ORP will show a very strong growth in Earnings Per Share. The EPS will grow by 26.00% on average per year.
ORP is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.93% yearly.
EPS Next Y12.98%
EPS Next 2Y32.97%
EPS Next 3Y26%
EPS Next 5YN/A
Revenue Next Year7.11%
Revenue Next 2Y6.48%
Revenue Next 3Y7.93%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ORP. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ORP. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

ORP's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ORP is cheaper than 78.26% of the companies in the same industry.
Industry RankSector Rank
P/FCF 3.88
EV/EBITDA N/A

4.3 Compensation for Growth

ORP's earnings are expected to grow with 26.00% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.97%
EPS Next 3Y26%

0

5. Dividend

5.1 Amount

No dividends for ORP!.
Industry RankSector Rank
Dividend Yield N/A

ORPEA

EPA:ORP (4/22/2024, 1:22:59 PM)

12.158

-0.09 (-0.75%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.94B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -27.42%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.17
Quick Ratio 0.16
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-6733.33%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y12.98%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)8.89%
Revenue growth 3Y7.76%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y